Chemycal has been acquired by 3E
Learn MoreDiscover how Chemycal PRO helps you boosting your regulatory monitoring:
Description of the draft amendment: Expanding scope of exemptions from manufacturing and import business licenses, clarifying scope of medical device advertisements, overhauling recall procedures for medical devices, establishing the management standards for integrated information of medical devices and Integrated Medical Device Information System (IMDIS) including UDI (Unique Device Identification), rationalizing GSP (Good Supply Practice).
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions